Radiation Oncology
Research group
Group Leader
Manuel Ignacio Algara López
The Radiation Oncology Research Group (GREOR) is a clinical and basic research group working on the use of radiation as a base of cancer treatment, especially in the lines of altered fractionation, radiotoxicity and quality of life, technological quality control and innovation; in addition to clinical projects linked to the clinical activity in the Radiation Oncology Service.
It is a multidisciplinary group comprising medical staff, physicists, technicians and nursing staff. The group has a significant scientific output in relation to radiation oncology groups in the area, besides activity to give research visibility.
Its main objective is to maintain the active lines of research, establish synergies with other groups, both national and international, to continue with the group’s training activities and the level of scientific output, and fundraising for both competitive and non-competitive funds, besides increasing its impact in society (popular science, clinical practice guidelines, patient groups and dissemination).
Members
Enric Fernández Velilla-Ceprià (Researcher)
Palmira Foro Arnalot (Researcher)
Ismael Membrive Conejo (Researcher)
Òscar Pera Cegarra (Researcher)
Jaume Quera Jordana (Researcher)
Anna Reig Castillejo (Researcher)
Núria Rodríguez de Dios (Researcher)
Javier Sanz Latiesas (Researcher)
M. Josefa Dengra Domingo (Technician)
Rafael Jiménez Lahuerta (Technician)
Main Publications
• Couñago F, Rodríguez de Dios N, Montemuiño S, Jové-Teixidó J, Martín M, Calvo-Crespo P, López-Mata M, Samper-Ots MP, López-Guerra JL, García-Cañibano T, et al. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society). Lung Canc 2018; 118: 119-127. IF 4.486. Q1.
• Rodríguez de Dios N, Couñago F, López JL, Calvo P, Murcia M, Rico M, Vallejo C, Luna J, Trueba I, Cigarral C, Farré N, Manero RM, Durán X, Samper P. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group. Clin Lung Cancer 2018; 19(5): e693-e697. IF 4.204. Q2.
• Maurel J, Sánchez-Cabús S, Laquente B, Gaba L, Visa L, Fabregat J, Poves I, Roselló S, Díaz-Beveridge R, Martín-Richard M, Rodríguez J, Sabater L, Conill C, Cambray M, Reig A, Ayuso JR, Valls C, Ferrández A, Bombí JA, Ginés A, García-Albéniz X, Fernández-Cruz L. Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine-erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial). Cancer Chemoth Pharm 2018; 82(6): 935-943. IF 2.808. Q2.
• Sanz J, Zhao M, Rodríguez de Dios N, Granado R, Foro P, Reig A, Membrive I, Algara M. Once-Weekly Hypofractionated Radiotherapy for Breast Cancer in Elderly Patients: Efficacy and Tolerance in 486 Patients. Biomed Res Int 2018; 2018: 8321871. IF 2.583. Q2.
Ongoing Research Projects
• Valoración de los beneficios de la rehabilitación profiláctica de la musculatura deglutoria sobre la calidad de vida y deglución, a corto y medio plazo, de los pacientes sometidos a radioterapia por cáncer de cabeza y cuello: Ensayo Clínico Aleatorizado
- Financing institution: Fundación Asociación Española Contra el Cáncer (PS14152556FORO)
- Period: from 2015 to 2019
- Principal investigator: Foro Arnalot, Palmira
Clinical Trials Signed in 2018
• OPTimizing Irradiation through Molecular Assessment of Lymph Node after primary sistemic treatment (OPTIMAL IIa)
- Register: GIC - RAD - 2016 - 01
- Principal investigator: Algara López, Manuel Ignacio
C/ Doctor Aiguader, 88
08003 Barcelona
(+34) 93 316 04 00
info@imim.es